Pierre Fiten

2.5k total citations
61 papers, 2.0k citations indexed

About

Pierre Fiten is a scholar working on Epidemiology, Oncology and Immunology. According to data from OpenAlex, Pierre Fiten has authored 61 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 21 papers in Oncology and 16 papers in Immunology. Recurrent topics in Pierre Fiten's work include Herpesvirus Infections and Treatments (16 papers), Protease and Inhibitor Mechanisms (13 papers) and Cell Adhesion Molecules Research (12 papers). Pierre Fiten is often cited by papers focused on Herpesvirus Infections and Treatments (16 papers), Protease and Inhibitor Mechanisms (13 papers) and Cell Adhesion Molecules Research (12 papers). Pierre Fiten collaborates with scholars based in Belgium, Italy and Sweden. Pierre Fiten's co-authors include Ghislain Opdenakker, Robert Snoeck, Graciela Andreï, Jo Van Damme, Erik De Clercq, Paul Proost, Raymond A. Dwek, Pauline M. Rudd, Martin Saunders and Heidi C. João and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Biochemistry.

In The Last Decade

Pierre Fiten

61 papers receiving 2.0k citations

Peers

Pierre Fiten

ONCOL

EPIDE

IMMUN

Carol Silverman United States

B. Kim Lee Sim United States

David Pye Australia

Shinya Suzu Japan

Robert Jan Lebbink Netherlands

Bernardetta Nardelli United States

Hiroki Sato Japan

Thomas Powell United States

Nicolas Blanchard France

R A Blanton United States

Carol Silverman United States

Pierre Fiten

1.6k ×2.3

548 ×0.9

ONCOL

426 ×0.7

EPIDE

1.1k ×2.3

IMMUN

392 ×0.9

Citations per year, relative to Pierre Fiten Pierre Fiten (= 1×) peers Carol Silverman

Countries citing papers authored by Pierre Fiten

Since Specialization

Citations

This map shows the geographic impact of Pierre Fiten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Fiten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Fiten more than expected).

Fields of papers citing papers by Pierre Fiten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Fiten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Fiten. The network helps show where Pierre Fiten may publish in the future.

Co-authorship network of co-authors of Pierre Fiten

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Fiten. A scholar is included among the top collaborators of Pierre Fiten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Fiten. Pierre Fiten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andreï, Graciela, Elisabet Van Loon, Evelyne Lerut, et al.. (2019). Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss. Antiviral Research. 168. 203–209. 12 indexed citations

Grünwald, Barbara T., Jennifer Vandooren, Erica Locatelli, et al.. (2016). Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer. Journal of Controlled Release. 239. 39–48. 55 indexed citations

Bauters, Tiene, Victoria Bordon, Elizaveta Padalko, et al.. (2016). Multidrug-resistant cytomegalovirus infection in a pediatric stem cell transplantation patient. Antiviral Research. 132. 149–153. 4 indexed citations

Piccard, Heléne, Jialiang Hu, Pierre Fiten, et al.. (2009). “Reverse degradomics”, monitoring of proteolytic trimming by multi‐CE and confocal detection of fluorescent substrates and reaction products. Electrophoresis. 30(13). 2366–2377. 11 indexed citations

Andreï, Graciela, Don B. Gammon, Pierre Fiten, et al.. (2006). Cidofovir Resistance in Vaccinia Virus Is Linked to Diminished Virulencein Mice. Journal of Virology. 80(19). 9391–9401. 70 indexed citations

Dillen, C, Pierre Fiten, Patrick Chaltin, et al.. (2006). Inhibition of Lethal Endotoxin Shock with an L-Pyridylalanine Containing Metalloproteinase Inhibitor Selected by High-Throughput Screening of a New Peptide Library. Combinatorial Chemistry & High Throughput Screening. 9(8). 599–611. 13 indexed citations

Martens, Erik, Ilse Van Aelst, Pierre Fiten, et al.. (2006). A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains. Biochimica et Biophysica Acta (BBA) - General Subjects. 1770(2). 178–186. 82 indexed citations

Winnepenninckx, Véronique, Maria Dêbiec‐Rychter, Jeroen A.M. Beliën, et al.. (2006). Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma. Modern Pathology. 19(9). 1170–1180. 22 indexed citations

Andreï, Graciela, Pierre Fiten, Erik De Clercq, Ghislain Opdenakker, & Robert Snoeck. (2005). Reduced pathogenicity of phenotypically and genotypically characterized cidofovir (CDV)-resistant vaccinia virus (VV). Antiviral Research. 1 indexed citations

10.

Nelissen, Inge, Koen Vandenbroeck, Pierre Fiten, et al.. (2000). Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis. Journal of Neuroimmunology. 105(1). 58–63. 40 indexed citations

11.

Vandenbroeck, Koen, Pierre Fiten, Isabelle Ronsse, et al.. (2000). High-resolution analysis of IL-6 minisatellite polymorphism in Sardinian multiple sclerosis: effect on course and onset of disease. Genes and Immunity. 1(7). 460–463. 17 indexed citations

12.

Nelissen, Inge, Pierre Fiten, Koen Vandenbroeck, et al.. (2000). PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia. Journal of Neuroimmunology. 108(1-2). 153–159. 23 indexed citations

13.

Fiten, Pierre, Koen Vandenbroeck, Bénédicte Dubois, et al.. (1999). Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development. Journal of Neuroimmunology. 95(1-2). 195–201. 18 indexed citations

14.

Masure, Stefan, Liesbet Paemen, Pierre Fiten, et al.. (1997). Production and Characterization of Recombinant Active Mouse Gelatinase B from Eukaryotic Cells and in vivo Effects after Intravenous Administration. European Journal of Biochemistry. 244(1). 21–30. 36 indexed citations

15.

Froyen, Guy, et al.. (1995). Effect of VH and VL consensus sequence-specific primers on the binding and neutralizing potential of a single-chain FV directed towards HuIFN-γ. Molecular Immunology. 32(7). 515–521. 8 indexed citations

16.

Anné, Jozef, Pierre Fiten, Lieve Van Mellaert, et al.. (1995). Analysis of the open reading frames of the main capsid proteins of actinophage VWB. Archives of Virology. 140(6). 1033–1047. 6 indexed citations

17.

Fiten, Pierre, et al.. (1994). Mouse Macrophage Derived Monocyte Chemotactic Protein-3: cDNA Cloning and Identification as MARC/FIC. Biochemical and Biophysical Research Communications. 201(2). 493–499. 27 indexed citations

18.

Rudd, Pauline M., Heidi C. João, Pierre Fiten, et al.. (1994). Glycoforms modify the dynamic stability and functional activity of an enzyme. Biochemistry. 33(1). 17–22. 247 indexed citations

19.

Opdenakker, Ghislain, et al.. (1993). Human Monocyte Chemotactic Protein-3 (MCP-3): Molecular Cloning of the cDNA and Comparison with Other Chemokines. Biochemical and Biophysical Research Communications. 191(2). 535–542. 97 indexed citations

20.

Ranst, Marc Van, et al.. (1992). Comparison of three non-isotopic automated DNA sequence analysis systems. Clinical Chemistry. 38(3). 465. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact